Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02061384 · ClinicalTrials.gov registry record · Phase 2
RA-2 13-cis Retinoic Acid (Isotretinoin)
A Phase 2 study, sponsored by University of Washington.
- Completed
- Registry status
- Phase 2
- Development phase
- 20
- Enrollment target
NCT02061384 is a Phase 2 study that has completed, run by University of Washington. The registered enrollment target is 20 participants.
The verdict
NCT02061384, a Phase 2 study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 20 participants
- Enrollment target
Study Summary
Men with infertility and normal hormone levels have few options for fertility treatment. Previous research work has suggested that men with infertility may have low levels of the active form of Vitamin A, called retinoic acid, in their testes. We think that giving men with low sperm counts retinoic acid may increase their sperm counts and improve their chances of fathering a pregnancy. We want to see if retinoic acid administration over twenty weeks can increase sperm production and help infertile men become fathers without the need for In vitro fertilization (IVF) and/or intracytoplasmic sperm injection (ICSI). We also want to see if adding calcitriol with retinoic acid will improve sperm motility in a sub-set of subjects.
Interventions
- DRUG Calcitriol
- DRUG 13-cis retinoic acid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2014-08 |
| Est. Completion | 2018-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02061384
The ClinicalTrials.gov registry entry for NCT02061384 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Calcitriol is the first listed.
NCT02061384 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02061384 about?
NCT02061384 is a clinical study titled "RA-2 13-cis Retinoic Acid (Isotretinoin)". Men with infertility and normal hormone levels have few options for fertility treatment. Previous research work has suggested that men with infertility may have low levels of the active form of Vitamin A, called retinoic acid, in their testes. We think that giving men with low sperm counts retinoic ...
What is the current status of trial NCT02061384?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 20 participants. The study started on 2014-08. Estimated completion is 2018-12.
What interventions are being tested in trial NCT02061384?
The interventions under investigation include: Calcitriol (DRUG), 13-cis retinoic acid (DRUG).
Who is sponsoring clinical trial NCT02061384?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.